Down-regulated expression of IKZF1 mRNA in peripheral blood mononuclear cells from patients with systemic lupus erythematosus
- 327 Downloads
Systemic lupus erythematosus (SLE) is a multi-system autoimmune disease with complex genetic inheritance. IKZF1 was established as a new susceptibility gene for SLE in a recent genome-wide association study (GWAS) in Chinese Han population. In order to examine whether expression levels of IKZF1 contribute to the pathogenesis of SLE, we estimated IKZF1 mRNA expression levels in peripheral blood mononuclear cells (PBMCs) via fluorescent quantitative reverse transcription polymerase chain reaction (RT-PCR) in 60 patients with SLE and 60 controls. We also explored whether the IKZF1 mRNA expression levels are associated with the variant of the SNP rs4917014 and the SLE Disease Activity Index (SLEDAI). The expression levels of IKZF1 mRNA in patients with SLE were significantly decreased compared with those in healthy controls (P < 0.001). No significant differences were found between IKZF1 mRNA expression levels and SLEDAI scores, SNP rs4917014. Our results suggest that decreased expression of IKZF1 mRNA may be correlated with the pathogenesis of SLE.
KeywordsIKZF1 Peripheral blood mononuclear cells Real-time reverse transcription–polymerase chain reaction Systemic lupus erythematosus
This work was supported by a grant from the General Program of National Natural Science Foundation of China (30972727) and the Foundation of the Excellent Young Scientist of Anhui Province (10040606Y10), We are most grateful to all the members who have so willingly participated in this study, which made this study possible.
- 8.Hochberg MC (1997) Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725. doi: 10.1002/1529-0131(199709)40:9<1725:AID-ART29>3.0.CO;2-Y PubMedCrossRefGoogle Scholar
- 11.Kirstetter P, Thomas M, Dierich A, Kastner P, Chan S (2002) Ikaros is critical for B cell differentiation and function. Eur J Immunol 32:720–730. doi: 10.1002/1521-4141(200203)32:3<720:AID-IMMU720>3.0.CO;2-P PubMedCrossRefGoogle Scholar
- 16.Palomino-Morales RJ, Rojas-Villarraga A, Gonzalez CI, Ramirez G, Anaya JM, Martin J (2008) STAT4 but not TRAF1/C5 variants influence the risk of developing rheumatoid arthritis and systemic lupus erythematosus in Colombians. Genes Immun 9:379–382. doi: 10.1038/gene.2008.30 PubMedCrossRefGoogle Scholar